Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Basilea Pharmaceutica International Ltd, Allschwil
Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
August 05, 2026
From
Basilea Pharmaceutica International Ltd, Allschwil
Via
GlobeNewswire
Basilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal fosmanogepix
July 29, 2026
From
Basilea Pharmaceutica International Ltd, Allschwil
Via
GlobeNewswire
Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
May 28, 2026
From
Basilea Pharmaceutica International Ltd, Allschwil
Via
GlobeNewswire
Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting
April 15, 2026
From
Basilea Pharmaceutica International Ltd, Allschwil
Via
GlobeNewswire
Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420
April 09, 2026
From
Basilea Pharmaceutica International Ltd, Allschwil
Via
GlobeNewswire
Basilea announces start of first‑in‑human study of novel antibiotic BAL2420
March 23, 2026
From
Basilea Pharmaceutica International Ltd, Allschwil
Via
GlobeNewswire
Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
February 25, 2026
From
Basilea Pharmaceutica International Ltd, Allschwil
Via
GlobeNewswire
Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance
February 17, 2026
From
Basilea Pharmaceutica International Ltd, Allschwil
Via
GlobeNewswire
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
February 09, 2026
From
Basilea Pharmaceutica International Ltd, Allschwil
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.